Capital World Investors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.75B | Sell |
41,283,933
-1,588,196
| -4% | -$222M | 0.78% | 26 |
|
|
2025
Q4 | $5.26B | Sell |
42,872,129
-2,307,802
| -5% | -$280M | 0.72% | 34 |
|
|
2025
Q3 | $5.02B | Sell |
45,179,931
-1,123,368
| -2% | -$128M | 0.69% | 35 |
|
|
2025
Q2 | $5.13B | Sell |
46,303,299
-7,244,602
| -14% | -$771M | 0.75% | 29 |
|
|
2025
Q1 | $6B | Sell |
53,547,901
-18,158,461
| -25% | -$1.87B | 0.97% | 18 |
|
|
2024
Q4 | $6.62B | Sell |
71,706,362
-4,842,566
| -6% | -$436M | 1.01% | 19 |
|
|
2024
Q3 | $6.42B | Buy |
76,548,928
+299,109
| +0.4% | +$22.8M | 0.99% | 19 |
|
|
2024
Q2 | $5.23B | Sell |
76,249,819
-8,247,585
| -10% | -$550M | 0.85% | 24 |
|
|
2024
Q1 | $6.19B | Buy |
84,497,404
+1,133,281
| +1% | +$87.1M | 1.02% | 17 |
|
|
2023
Q4 | $6.75B | Buy |
83,364,123
+1,642,736
| +2% | +$128M | 1.2% | 12 |
|
|
2023
Q3 | $6.12B | Buy |
81,721,387
+792,071
| +1% | +$60.9M | 1.21% | 14 |
|
|
2023
Q2 | $6.24B | Buy |
80,929,316
+4,429,076
| +6% | +$353M | 1.2% | 14 |
|
|
2023
Q1 | $6.35B | Buy |
76,500,240
+7,607,268
| +11% | +$630M | 1.31% | 13 |
|
|
2022
Q4 | $5.91B | Buy |
68,892,972
+11,130,228
| +19% | +$881M | 1.26% | 13 |
|
|
2022
Q3 | $3.56B | Buy |
57,762,744
+4,903,276
| +9% | +$309M | 0.8% | 24 |
|
|
2022
Q2 | $3.27B | Buy |
52,859,468
+3,357,616
| +7% | +$208M | 0.69% | 29 |
|
|
2022
Q1 | $2.94B | Buy |
49,501,852
+6,820,228
| +16% | +$436M | 0.51% | 43 |
|
|
2021
Q4 | $3.1B | Buy |
42,681,624
+5,705,315
| +15% | +$393M | 0.49% | 44 |
|
|
2021
Q3 | $2.58B | Buy |
36,976,309
+988,974
| +3% | +$69.5M | 0.44% | 49 |
|
|
2021
Q2 | $2.48B | Buy |
35,987,335
+903,841
| +3% | +$60.4M | 0.42% | 56 |
|
|
2021
Q1 | $2.27B | Sell |
35,083,494
-3,451,094
| -9% | -$223M | 0.42% | 57 |
|
|
2020
Q4 | $2.24B | Sell |
38,534,588
-807,861
| -2% | -$48.7M | 0.43% | 57 |
|
|
2020
Q3 | $2.49B | Sell |
39,342,449
-4,161,381
| -10% | -$289M | 0.54% | 45 |
|
|
2020
Q2 | $3.35B | Sell |
43,503,830
-2,827,488
| -6% | -$217M | 0.81% | 28 |
|
|
2020
Q1 | $3.46B | Buy |
46,331,318
+25,555,467
| +123% | +$1.77B | 1.01% | 20 |
|
|
2019
Q4 | $1.35B | Sell |
20,775,851
-452,643
| -2% | -$29.5M | 0.3% | 89 |
|
|
2019
Q3 | $1.35B | Sell |
21,228,494
-497,087
| -2% | -$32.5M | 0.32% | 87 |
|
|
2019
Q2 | $1.47B | Buy |
21,725,581
+5,485,081
| +34% | +$361M | 0.34% | 82 |
|
|
2019
Q1 | $1.06B | Buy |
16,240,500
+1,217,836
| +8% | +$80.9M | 0.26% | 100 |
|
|
2018
Q4 | $940M | Buy |
15,022,664
+1,766,423
| +13% | +$123M | 0.25% | 108 |
|
|
2018
Q3 | $1.02B | Buy |
13,256,241
+1,317,178
| +11% | +$99.5M | 0.25% | 110 |
|
|
2018
Q2 | $846M | Sell |
11,939,063
-866,937
| -7% | -$61.2M | 0.18% | 128 |
|
|
2018
Q1 | $965M | Buy |
12,806,000
+812,000
| +7% | +$64.5M | 0.22% | 117 |
|
|
2017
Q4 | $859M | Buy |
11,994,000
+6,961,400
| +138% | +$529M | 0.19% | 127 |
|
|
2017
Q3 | $408M | Buy |
5,032,600
+3,002,850
| +148% | +$230M | 0.09% | 178 |
|
|
2017
Q2 | $144M | Sell |
2,029,750
-9,044,999
| -82% | -$602M | 0.03% | 250 |
|
|
2017
Q1 | $752M | Sell |
11,074,749
-4,744,199
| -30% | -$334M | 0.18% | 119 |
|
|
2016
Q4 | $1.13B | Buy |
15,818,948
+500,000
| +3% | +$37.2M | 0.28% | 92 |
|
|
2016
Q3 | $1.21B | Hold |
15,318,948
| – | – | 0.32% | 81 |
|
|
2016
Q2 | $1.28B | Buy |
15,318,948
+3,380,000
| +28% | +$300M | 0.34% | 76 |
|
|
2016
Q1 | $1.1B | Buy |
11,938,948
+1,851,758
| +18% | +$167M | 0.3% | 90 |
|
|
2015
Q4 | $1.02B | Sell |
10,087,190
-110,000
| -1% | -$11.4M | 0.29% | 89 |
|
|
2015
Q3 | $1B | Hold |
10,197,190
| – | – | 0.29% | 92 |
|
|
2015
Q2 | $1.19B | Hold |
10,197,190
| – | – | 0.32% | 82 |
|
|
2015
Q1 | $1B | Sell |
10,197,190
-495,000
| -5% | -$50.3M | 0.27% | 98 |
|
|
2014
Q4 | $1.01B | Sell |
10,692,190
-15,765,000
| -60% | -$1.63B | 0.27% | 90 |
|
|
2014
Q3 | $2.82B | Sell |
26,457,190
-12,149,220
| -31% | -$1.19B | 0.79% | 33 |
|
|
2014
Q2 | $3.2B | Sell |
38,606,410
-2,340,813
| -6% | -$182M | 0.88% | 28 |
|
|
2014
Q1 | $2.9B | Sell |
40,947,223
-15,415,267
| -27% | -$1.21B | 0.83% | 29 |
|
|
2013
Q4 | $4.24B | Sell |
56,362,490
-13,052,922
| -19% | -$909M | 1.19% | 18 |
|
|
2013
Q3 | $4.36B | Sell |
69,415,412
-6,635,500
| -9% | -$397M | 1.32% | 16 |
|
|
2013
Q2 | $3.89B | Buy |
+76,050,912
| New | +$3.96B | 1.26% | 16 |
|
Other funds holding GILD
VCM
VPM
Capital World Investors's GILD Position: Q1 2026 in Review
Capital World Investors reduced its Gilead Sciences (GILD) stake by 3.7% in Q1 2026, selling an estimated $222M and leaving 41,283,933 shares worth $5.75B. The position accounts for 0.78% of the portfolio, ranked #26.
Capital World Investors first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.75B in Q4 2023. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Capital World Investors held 41,283,933 shares of Gilead Sciences worth $5.75B as of Q1 2026.
- Capital World Investors sold 1,588,196 Gilead Sciences shares in Q1 2026, an estimated $222M.
- Gilead Sciences made up 0.78% of Capital World Investors's portfolio in Q1 2026, its #26 holding.
- Capital World Investors first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Capital World Investors's Gilead Sciences position peaked at $6.75B in Q4 2023.
- 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Capital World Investors's 13F filing for Q1 2026, filed 13 May 2026.